BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34043589)

  • 1. Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.
    Lopez-Ramirez MA; Lai CC; Soliman SI; Hale P; Pham A; Estrada EJ; McCurdy S; Girard R; Verma R; Moore T; Lightle R; Hobson N; Shenkar R; Poulsen O; Haddad GG; Daneman R; Gongol B; Sun H; Lagarrigue F; Awad IA; Ginsberg MH
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34043589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease.
    Lai CC; Nelsen B; Frias-Anaya E; Gallego-Gutierrez H; Orecchioni M; Herrera V; Ortiz E; Sun H; Mesarwi OA; Ley K; Gongol B; Lopez-Ramirez MA
    Circ Res; 2022 Nov; 131(11):909-925. PubMed ID: 36285625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
    Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
    EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
    Zhou Z; Tang AT; Wong WY; Bamezai S; Goddard LM; Shenkar R; Zhou S; Yang J; Wright AC; Foley M; Arthur JS; Whitehead KJ; Awad IA; Li DY; Zheng X; Kahn ML
    Nature; 2016 Apr; 532(7597):122-6. PubMed ID: 27027284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.
    Zhou HJ; Qin L; Jiang Q; Murray KN; Zhang H; Li B; Lin Q; Graham M; Liu X; Grutzendler J; Min W
    Nat Commun; 2021 Jan; 12(1):504. PubMed ID: 33495460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
    Li J; Zhao Y; Coleman P; Chen J; Ting KK; Choi JP; Zheng X; Vadas MA; Gamble JR
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165519. PubMed ID: 31369819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice.
    Li J; Zhao Y; Choi J; Ting KK; Coleman P; Chen J; Cogger VC; Wan L; Shi Z; Moller T; Zheng X; Vadas MA; Gamble JR
    PLoS Biol; 2020 Jun; 18(6):e3000734. PubMed ID: 32502201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
    Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
    Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.
    Qin L; Zhang H; Li B; Jiang Q; Lopez F; Min W; Zhou JH
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):2943-2960. PubMed ID: 34670407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF signalling enhances lesion burden in KRIT1 deficient mice.
    DiStefano PV; Glading AJ
    J Cell Mol Med; 2020 Jan; 24(1):632-639. PubMed ID: 31746130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
    Lopez-Ramirez MA; Pham A; Girard R; Wyseure T; Hale P; Yamashita A; Koskimäki J; Polster S; Saadat L; Romero IA; Esmon CT; Lagarrigue F; Awad IA; Mosnier LO; Ginsberg MH
    Blood; 2019 Jan; 133(3):193-204. PubMed ID: 30442679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression.
    Castro M; Laviña B; Ando K; Álvarez-Aznar A; Abu Taha A; Brakebusch C; Dejana E; Betsholtz C; Gaengel K
    Circ Res; 2019 Apr; 124(8):1240-1252. PubMed ID: 30732528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.
    Louvi A; Chen L; Two AM; Zhang H; Min W; Günel M
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3737-42. PubMed ID: 21321212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
    You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
    J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.
    Jenny Zhou H; Qin L; Zhang H; Tang W; Ji W; He Y; Liang X; Wang Z; Yuan Q; Vortmeyer A; Toomre D; Fuh G; Yan M; Kluger MS; Wu D; Min W
    Nat Med; 2016 Sep; 22(9):1033-1042. PubMed ID: 27548575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation.
    Weng J; Yang Y; Song D; Huo R; Li H; Chen Y; Nam Y; Zhou Q; Jiao Y; Fu W; Yan Z; Wang J; Xu H; Di L; Li J; Wang S; Zhao J; Wang J; Cao Y
    Am J Hum Genet; 2021 May; 108(5):942-950. PubMed ID: 33891857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral cavernous malformations arise independent of the heart of glass receptor.
    Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
    Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Cell-Pericyte Interactions in the Pathogenesis of Cerebral Cavernous Malformations (CCMs).
    Min W; Zhou JH
    Cold Spring Harb Perspect Med; 2023 Mar; 13(3):. PubMed ID: 35667709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.